Popular Articles

Anadys Pharmaceuticals Receives FDA Clearance Of Phase II Protocol To Study ANA598 In Combination With Interferon-Alpha And Ribavirin In HCV Patients
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced finalization of the protocol for the Company"s Phase II trial of ANA598 in combination with pegylated interferon-alpha and ribavirin in hepatitis C patients. Allowance of the protocol has been received from the United States Food and Drug Administration (FDA), and patient dosing is expected to commence within the next several weeks.
generic viagra online
Which? Warns Consumers Against Costly Genetic Tests
As the Lords Science Committee publishes its report on genomic medicine, Which? scientific policy adviser, Dr Rob Reid, says:
News of the day
Council Recognises Champions Of Pharmacy
Two pharmacists, and one non-pharmacist, have been recognised by the Council of the Royal
Public Health

Seniors Find Medicare Part D Too Complicated To Identify Lowest-Cost Plan

In the face of rising health care costs, a new study has found that older adults were less likely to identify the plan that minimized their total annual cost and were likely to mistakenly think they had chosen the lowest-cost plan. The study, funded by the Robert Wood Johnson Foundation® Investigator Awards in Health Policy Research, is currently available online, and will be published in the August 2009 issue of Health Services Research. "Many seniors are unaware that they can be saving hundreds of dollars every year by choosing a different drug plan, because there are entirely too many choices for them to navigate," said Yaniv Hanoch, Ph.D., lead author and lecturer at the University of Plymouth, School of Psychology, Plymouth, U.K. "The system should limit choice and empower its beneficiaries to make informed and cost-effective decisions about their prescription drug plan." Hanoch and colleagues took an in-depth look at the consumer behavior patterns of nearly two hundred mentally and physically healthy individuals age 18 and older, half age 65 or older. Participants were randomly assigned to choose among 3, 10, or 20 hypothetical Medicare prescription drug plans. The researchers found that - regardless of age - an increase in the number of insurance plans available reduced the likelihood of picking the plan with the lowest annual costs. Other factual questions about the plans were also more likely to be answered incorrectly when participants had more plans to choose from. While older adults were less able than younger ones to choose the plan that offered the lowest annual costs, they were also more confident that their decisions were correct. The authors recommend a few options for improving the system: offering one choice that seniors can opt in or out of (like Medicare Parts A and B); standardizing the benefit; or reducing the number of plans to 10 or less. "Making Part D easier for seniors to navigate should be part of the administration"s and Congress" efforts to reform health care," says Thomas Rice, Ph.D., co-author and professor of health services in the UCLA School of Public Health. "When it comes to Medicare Part D, research shows that seniors prefer less choice and more government intervention." Other findings, including a study published earlier this year by Hanoch and colleagues, show that a majority of adults believe that Medicare Part D is too complicated and difficult to comprehend. Most adults favor some form of simplification and support the idea of being able to purchase a plan directly from Medicare. Furthermore, changes in drug consumption and insurance formulary coverage could lead to spikes in a consumer"s out-of-pocket expenditures, sometimes by more than $1,000. Because the system is so difficult to navigate, seniors have been reluctant to switch plans during the annual open enrollment period. Notes: The study, "How Much Choice Is Too Much? The Case of the Medicare Prescription Drug Benefit" is available online at http://www3.interscience.wiley.com/journal/122407933/abstract. Additional coauthors include Janet Cummings, B.A., with the Department of Health Services, UCLA School of Public Health, Los Angeles, Calif., and Stacey Wood, Ph.D., with the Department of Psychology, Scripps College, Claremont, Calif. Natalia Barolin Investigator Awards in Health Policy Research


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):